Literature DB >> 12140282

Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis.

Vera Gorbunova1, Andrei Seluanov, Olivia M Pereira-Smith.   

Abstract

Cells subjected to sub-lethal doses of stress such as irradiation or oxidative damage enter a state that closely resembles replicative senescence. What triggers stress-induced premature senescence (SIPS) and how similar this mechanism is to replicative senescence are not well understood. It has been suggested that stress-induced senescence is caused by rapid telomere shortening resulting from DNA damage. In order to test this hypothesis directly, we examined whether overexpression of the catalytic subunit of human telomerase (hTERT) can protect cells from SIPS. We therefore analyzed the response of four different lines of normal human fibroblasts with and without hTERT to stress induced by UV, gamma-irradiation, and H(2)O(2). SIPS was induced with the same efficiency in normal and hTERT-immortalized cells. This suggests that SIPS is not triggered by telomere shortening and that nonspecific DNA damage serves as a signal for induction of SIPS. Although telomerase did not protect cells from SIPS, fibroblasts expressing hTERT were more resistant to stress-induced apoptosis and necrosis. We hypothesize that healing of DNA breaks by telomerase inhibits the induction of cell death, but because healing does not provide legitimate DNA repair, it does not protect cells from SIPS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140282     DOI: 10.1074/jbc.M202671200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  When cells get stressed: an integrative view of cellular senescence.

Authors:  Ittai Ben-Porath; Robert A Weinberg
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 2.  In search of "stemness".

Authors:  Jingli Cai; Mark L Weiss; Mahendra S Rao
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

3.  TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination.

Authors:  Zhiyong Mao; Andrei Seluanov; Ying Jiang; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

4.  Smurf2 up-regulation activates telomere-dependent senescence.

Authors:  Hong Zhang; Stanley N Cohen
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

5.  5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation.

Authors:  Alfonso Catalano; Sabrina Rodilossi; Paola Caprari; Vincenzo Coppola; Antonio Procopio
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

6.  Telomerase is involved in IL-7-mediated differential survival of naive and memory CD4+ T cells.

Authors:  Yinhua Yang; Jie An; Nan-ping Weng
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

7.  Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways.

Authors:  Karl E Herbert; Yogita Mistry; Richard Hastings; Toryn Poolman; Laura Niklason; Bryan Williams
Journal:  Circ Res       Date:  2007-11-08       Impact factor: 17.367

Review 8.  Coevolution of telomerase activity and body mass in mammals: from mice to beavers.

Authors:  Vera Gorbunova; Andrei Seluanov
Journal:  Mech Ageing Dev       Date:  2008-02-23       Impact factor: 5.432

9.  Significance of cellular senescence in aging and cancer.

Authors:  Angela Grimes; Sathees B C Chandra
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679

10.  Mycosporine-like amino acids extracted from scallop (Patinopecten yessoensis) ovaries: UV protection and growth stimulation activities on human cells.

Authors:  Chiaki Oyamada; Masaki Kaneniwa; Koji Ebitani; Masakazu Murata; Kenji Ishihara
Journal:  Mar Biotechnol (NY)       Date:  2007-12-22       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.